Fig. 1 · Structure
Documents & Downloads
(±)19(20)-EDP ethanolamide
Interleukin Related
(±)19(20)-EDP ethanolamide, a derivative of ω-3 endocannabinoids, acts primarily through the modulation of interleukin signaling pathways. This compound exhibits significant anti-inflammatory properties, particularly in neuroinflammation studies, and demonstrates antiangiogenic effects on vascular endothelial cells. Additionally, it induces vasodilation in coronary arteries, making it a valuable tool for research focused on cytokine interactions and vascular biology.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 2123485-34-5 |
| Applications | Interleukin Related |
| Formula | C24H37NO3 |
| Molecular Weight | 387.56 |
| Synonyms | 19,20-DHEA epoxide; 19,20-Epoxy docosapentaenoic acid ethanolamide; 19,20-EDP-EA |
| SMILES | OCCNC(CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC1C(O1)CC)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.